Pfizer applies for FDA authorization for Omicron-retooled vaccine booster in kids under 5

Pfizer Inc (PFE.N) and its German partner BioNTech SE (22UAy.DE)said on Monday they have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization of their Omicron-adapted COVID-19 vaccine booster for children aged 6 months through 4 years.